Lineage Cell Therapeutics
LCTX
#8551
Rank
S$0.35 B
Marketcap
S$1.41
Share price
-4.31%
Change (1 day)
-5.79%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -S$29.33 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are S$14.77 Million. In 2025 the company made an earning of -S$27.76 Million a decrease over its 2024 earnings that were of -S$27.38 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$29.33 Million5.63%
2025 -S$27.76 Million1.4%
2024 -S$27.38 Million-13.16%
2023 -S$31.53 Million9.83%
2022 -S$28.71 Million-54.24%
2021 -S$62.72 Million86.07%
2020 -S$33.71 Million-31.97%
2019 -S$49.55 Million-5.42%
2018 -S$52.39 Million1.1%
2017 -S$51.82 Million-31.06%
2016 -S$75.16 Million-10.38%
2015 -S$83.87 Million29.69%
2014 -S$64.67 Million31.68%
2013 -S$49.12 Million
2011 -S$23.84 Million89.78%
2010 -S$12.56 Million206.06%
2009 -S$4.11 Million-0.58%
2008 -S$4.13 Million164.89%
2007 -S$1.56 Million-30.22%
2006 -S$2.24 Million
2002 -S$2.6 Million-41.04%
2001 -S$4.4 Million-32.04%
2000 -S$6.48 Million-11.85%
1999 -S$7.35 Million
1997 -S$4.72 Million12.12%
1996 -S$4.21 Million106.25%
1995 -S$2.04 Million-11.11%
1994 -S$2.3 Million50%
1993 -S$1.53 Million20%
1992 -S$1.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.2 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA